Literature DB >> 30891628

Epigenetic regulation of T helper cells and intestinal pathogenicity.

Yuya Hagihara1, Yusuke Yoshimatsu1, Yohei Mikami2, Yoshiaki Takada1, Shinta Mizuno1, Takanori Kanai1,3.   

Abstract

Inflammatory bowel diseases (IBDs) are characterized by relapsing and remitting chronic intestinal inflammation. Previous studies have demonstrated the contributions of genetic background, environmental factors (food, microbiota, use of antibiotics), and host immunity in the development of IBDs. More than 200 genes have been shown to influence IBD susceptibility, most of which are involved in immunity. The vertebrate immune system comprises a complex network of innate and adaptive immune cells that protect the host from infection and cancer. Dysregulation of the mutualistic relationship between the immune system and the gut environment results in IBD. Considering the fundamental role of epigenetic regulation in immune cells, epigenetic mechanisms, particularly in T helper (Th) cells, may play a major role in the complex regulation of mucosal immunity. Epigenetic regulation and dysregulation of Th cells are involved in the maintenance of intestinal homeostasis and its breakdown in IBD.

Entities:  

Keywords:  CD4 T cell; Colitis; Epigenetic regulation; Inflammatory bowel disease; Mucosal immunology

Year:  2019        PMID: 30891628     DOI: 10.1007/s00281-019-00732-9

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  242 in total

Review 1.  Epigenetic regulation of T cell fate and function.

Authors:  Christopher B Wilson; Karen W Makar; Mercedes Pérez-Melgosa
Journal:  J Infect Dis       Date:  2002-02-15       Impact factor: 5.226

Review 2.  H3K27 demethylases, at long last.

Authors:  Tomek Swigut; Joanna Wysocka
Journal:  Cell       Date:  2007-10-05       Impact factor: 41.582

Review 3.  Epigenetic dynamics during CD4(+) T cells lineage commitment.

Authors:  Ramon M Rodriguez; Carlos Lopez-Larrea; Beatriz Suarez-Alvarez
Journal:  Int J Biochem Cell Biol       Date:  2015-05-11       Impact factor: 5.085

4.  Bioactive IL-18 expression is up-regulated in Crohn's disease.

Authors:  G Monteleone; F Trapasso; T Parrello; L Biancone; A Stella; R Iuliano; F Luzza; A Fusco; F Pallone
Journal:  J Immunol       Date:  1999-07-01       Impact factor: 5.422

5.  Helios induces epigenetic silencing of IL2 gene expression in regulatory T cells.

Authors:  Ian Baine; Samik Basu; Rachel Ames; Rani S Sellers; Fernando Macian
Journal:  J Immunol       Date:  2012-12-28       Impact factor: 5.422

6.  A protective function for interleukin 17A in T cell-mediated intestinal inflammation.

Authors:  William O'Connor; Masahito Kamanaka; Carmen J Booth; Terrence Town; Susumu Nakae; Yoichiro Iwakura; Jay K Kolls; Richard A Flavell
Journal:  Nat Immunol       Date:  2009-06       Impact factor: 25.606

7.  Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression.

Authors:  Sheng Xiao; Hulin Jin; Thomas Korn; Sue M Liu; Mohamed Oukka; Bing Lim; Vijay K Kuchroo
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

8.  The MicroRNA-183-96-182 Cluster Promotes T Helper 17 Cell Pathogenicity by Negatively Regulating Transcription Factor Foxo1 Expression.

Authors:  Kenji Ichiyama; Alicia Gonzalez-Martin; Byung-Seok Kim; Hyun Yong Jin; Wei Jin; Wei Xu; Mohsen Sabouri-Ghomi; Shunbin Xu; Pan Zheng; Changchun Xiao; Chen Dong
Journal:  Immunity       Date:  2016-06-21       Impact factor: 31.745

9.  SOCS1 is essential for regulatory T cell functions by preventing loss of Foxp3 expression as well as IFN-{gamma} and IL-17A production.

Authors:  Reiko Takahashi; Shuhei Nishimoto; Go Muto; Takashi Sekiya; Taiga Tamiya; Akihiro Kimura; Rimpei Morita; Mayako Asakawa; Takatoshi Chinen; Akihiko Yoshimura
Journal:  J Exp Med       Date:  2011-09-05       Impact factor: 14.307

Review 10.  Role of Th17 Cells in the Pathogenesis of Human IBD.

Authors:  Julio Gálvez
Journal:  ISRN Inflamm       Date:  2014-03-25
View more
  7 in total

1.  Pathogenicity of acquired immunity in human diseases.

Authors:  Kiyoshi Hirahara
Journal:  Semin Immunopathol       Date:  2019-05-07       Impact factor: 9.623

2.  A New Role for Conivaptan in Ulcerative Colitis in Mice: Inhibiting Differentiation of CD4+T Cells into Th1 Cells.

Authors:  Dandan Dou; Yuge Ji; Junjie Zheng; Jingxin Li; Xiaolong Zhu; Shuhai Tang; Hongjuan Wang; Qin Li; Haiyan Jing
Journal:  Dig Dis Sci       Date:  2021-11-09       Impact factor: 3.487

3.  Paeoniflorin ameliorates ulcerative colitis by modulating the dendritic cell-mediated TH17/Treg balance.

Authors:  Kai Zheng; Jia Jia; Shihai Yan; Hong Shen; Ping Zhu; Jiangyi Yu
Journal:  Inflammopharmacology       Date:  2020-05-29       Impact factor: 4.473

Review 4.  Bacteriotherapy for inflammatory bowel disease.

Authors:  Yusuke Yoshimatsu; Yohei Mikami; Takanori Kanai
Journal:  Inflamm Regen       Date:  2021-01-13

5.  Editorial: CD4+ T Cells in Cancer Immunotherapies.

Authors:  José M González-Navajas; Eyad Elkord; Jongdae Lee
Journal:  Front Immunol       Date:  2021-09-06       Impact factor: 7.561

Review 6.  New Insights Into the Epigenetic Regulation of Inflammatory Bowel Disease.

Authors:  Jing Xu; Hao-Ming Xu; Mei-Feng Yang; Yu-Jie Liang; Quan-Zhou Peng; Yuan Zhang; Cheng-Mei Tian; Li-Sheng Wang; Jun Yao; Yu-Qiang Nie; De-Feng Li
Journal:  Front Pharmacol       Date:  2022-01-31       Impact factor: 5.810

Review 7.  Pathogenesis and management of gastrointestinal inflammation and fibrosis: from inflammatory bowel diseases to endoscopic surgery.

Authors:  Kentaro Iwata; Yohei Mikami; Motohiko Kato; Naohisa Yahagi; Takanori Kanai
Journal:  Inflamm Regen       Date:  2021-07-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.